A Risk Profile Using Simple Hematologic Parameters to Assess Benefits From Baricitinib in Patients Hospitalized With COVID-19: A Post Hoc Analysis of the Adaptive COVID-19 Treatment Trial-2
利用简单的血液学参数评估巴瑞替尼治疗COVID-19住院患者的获益风险概况:一项针对COVID-19适应性治疗试验-2的事后分析
期刊:Annals of Internal Medicine
影响因子:15.2
doi:10.7326/M23-2593
Paules, Catharine I; Wang, Jing; Tomashek, Kay M; Bonnett, Tyler; Singh, Kanal; Marconi, Vincent C; Davey, Richard T Jr; Lye, David C; Dodd, Lori E; Yang, Otto O; Benson, Constance A; Deye, Gregory A; Doernberg, Sarah B; Hynes, Noreen A; Grossberg, Robert; Wolfe, Cameron R; Nayak, Seema U; Short, William R; Voell, Jocelyn; Potter, Gail E; Rapaka, Rekha R